Vaxcyte, Inc. (PCVX) Tops Q2 EPS by 5c
Vaxcyte, Inc. (NASDAQ: PCVX) reported Q2 EPS of ($0.70), $0.05 better than the analyst estimate of ($0.75).
For earnings history and earnings-related data on Vaxcyte, Inc. (PCVX) click here.
Vaxcyte, Inc. (NASDAQ: PCVX) reported Q2 EPS of ($0.70), $0.05 better than the analyst estimate of ($0.75).
For earnings history and earnings-related data on Vaxcyte, Inc. (PCVX) click here.